Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?

• Published in: Current allergy and asthma reports 2021-02, Vol.21 (2), p.6, Article 6
• Main Authors: Zeng, Ming, Wang, De-Yun, Mullol, Joaquim, Liu, Zheng
• Format: Article
• Language: English
• Subjects: Allergology; Coronaviruses; COVID-19; COVID-19 - complications; COVID-19 - epidemiology; COVID-19 - ethnology; Demography; Ethnicity; Global Health; Humans; Medicine; Medicine & Public Health; Olfaction Disorders - complications; Pandemics; Prevalence; Rhinosinusitis (J Mullol; Rhinosinusitis (J Mullol, Section Editor); SARS-CoV-2; Section Editor; Surveys and Questionnaires; Taste disorders; Taste Disorders - complications; Topical Collection on Rhinosinusitis
• ISSN: 1529-7322; 1534-6315; 1534-6315
• DOI: 10.1007/s11882-020-00987-5

Purpose of Review Chemosensory dysfunction in the patients with COVID-19 has been reported frequently in the studies from different regions of the world. However, the prevalence of smell and/or taste disorders presents significant ethnic and geographic variability. In addition, the pathogenesis of chemosensory dysfunction remains unclarified. Recent Findings This is a narrative review on the recent state of the prevalence, mechanism, and diagnostic and therapeutic strategy of chemosensory dysfunction in COVID-19 patients during the global pandemic. The chemosensory dysfunction was analysis based on recent studies, which either used questionnaires, Likert scales (0–10), or smell tests to estimate the smell and taste dysfunction. The ethnic and geographic difference of the prevalence of smell and/or taste disorders and the potential underlying mechanisms have been discussed. Several suggestions on the diagnosis and treatment of COVID-19 patients with smell and taste disorders were summarized for the physicians. Summary This review provides a comprehensive overview of the current studies regarding the chemosensory dysfunction during the COVID-19 worldwide outbreak.